Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: A study by the French Society of Bone Marrow Transplantation and Cellular Therapy

J. Gauthier, L. Castagna, F. Garnier, T. Guillaume, G. Socié, S. Maury, N. Maillard, R. Tabrizi, T. Marchand, J. Malfuson, A. Gac, E. Gyan, M. Mercier, Y. Béguin, J. Delage, P. Turlure, A. Marçais, S. Nguyen, R. Dulery, J. BayA. Huynh, E. Daguindau, J. Cornillon, C. Régny, M. Michallet, R. Peffault De Latour, I. Yakoub-Agha, D. Blaise

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)689-696
Number of pages8
JournalBone Marrow Transplantation
Volume52
Issue number5
DOIs
Publication statusPublished - 2017

Cite this

Gauthier, J., Castagna, L., Garnier, F., Guillaume, T., Socié, G., Maury, S., Maillard, N., Tabrizi, R., Marchand, T., Malfuson, J., Gac, A., Gyan, E., Mercier, M., Béguin, Y., Delage, J., Turlure, P., Marçais, A., Nguyen, S., Dulery, R., ... Blaise, D. (2017). Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: A study by the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation, 52(5), 689-696. https://doi.org/10.1038/bmt.2016.349